Article
Restricting datasets to classifiable samples augments discovery of immune disease biomarkers
26 Jun 2024
Abstract excerpt
Immunological diseases are typically heterogeneous in clinical presentation, severity and response to therapy. Biomarkers of immune diseases often reflect this variability, especially compared to their regulated behaviour in health. This leads to a common difficulty that frustrates biomarker discovery and interpretation - namely, unequal dispersion of immune disease biomarker expression between patient classes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
